Hughes Eric A's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 52,742 Ordinary Shares done . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 52,742 | 52,742 (0%) | 0% | - | Ordinary Shares | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 52,742 | 52,744 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 15.16 per share. | 01 Aug 2025 | 52,742 | 0 (0%) | 0% | 15.2 | 799,437 | Ordinary Shares |
| Monte Rosa Therapeutics Inc | Eric A Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 30,700 | 30,700 | - | - | Stock Option (Right to Buy) | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 78,616 | 78,616 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 23,251 | 69,754 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 23,251 | 23,251 (0%) | 0% | - | Ordinary Shares | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 04 Mar 2025 | 15,174 | 8,077 (0%) | 0% | 15.7 | 238,757 | Ordinary Shares |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 04 Mar 2025 | 8,077 | 0 (0%) | 0% | 15.9 | 128,531 | Ordinary Shares |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 24,900 | 49,801 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 24,900 | 24,900 (0%) | 0% | - | Ordinary Shares | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 16.19 per share. | 03 Mar 2025 | 19,726 | 5,174 (0%) | 0% | 16.2 | 319,275 | Ordinary Shares |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 15.56 per share. | 03 Mar 2025 | 5,174 | 0 (0%) | 0% | 15.6 | 80,495 | Ordinary Shares |
| Monte Rosa Therapeutics Inc | Hughes Eric A | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2024 | 44,200 | 44,200 | - | - | Stock Option (Right to Buy) | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 17.38 per share. | 09 Aug 2024 | 45,060 | 0 (0%) | 0% | 17.4 | 782,972 | Ordinary Shares |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 52,742 | 105,486 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 52,742 | 69,597 (0%) | 0% | - | Ordinary Shares | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 17.25 per share. | 01 Aug 2024 | 24,537 | 45,060 (0%) | 0% | 17.3 | 423,280 | Ordinary Shares |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 93,005 | 93,005 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 24,900 | 74,701 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 24,900 | 24,900 (0%) | 0% | - | Ordinary Shares | |
| Teva Pharmaceutical Industries | Eric A Hughes | See "Remarks" | Sale of securities on an exchange or to another person at price $ 13.34 per share. | 03 Mar 2024 | 8,045 | 16,855 (0%) | 0% | 13.3 | 107,299 | Ordinary Shares |